ArticleNature communications2026

Targeting the Ip6k2-Runx2 axis disrupts osteoblast-osteoclast coupling to treat osteoporosis.

Guixing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.